🔗 Share this article

Texas Attorney General Ken Paxton is taking legal action against the makers of acetaminophen, alleging the companies withheld potential risks that the medication presented to children's brain development.

The lawsuit follows a month after Donald Trump advocated an unsubstantiated connection between using Tylenol - alternatively called acetaminophen - throughout gestation and autism in young ones.

The attorney general is taking legal action against the pharmaceutical giant, which formerly manufactured the drug, the only pain reliever approved for pregnant women, and the current manufacturer, which presently makes it.

In a statement, he claimed they "deceived the public by profiting off of suffering and marketing drugs ignoring the potential hazards."

Kenvue says there is no credible evidence connecting acetaminophen to autism.

"These corporations lied for decades, intentionally threatening numerous people to increase profits," Paxton, a Republican, declared.

The company said in a statement that it was "deeply concerned by the perpetuation of misinformation on the reliability of paracetamol and the potential impact that could have on the health of US mothers and children."

On its official site, the company also stated it had "consistently assessed the pertinent research and there is insufficient valid information that shows a established connection between using paracetamol and autism."

Organizations speaking for medical professionals and health professionals share this view.

ACOG has said acetaminophen - the main ingredient in acetaminophen - is a restricted selection for expectant mothers to manage discomfort and elevated temperature, which can present major wellness concerns if ignored.

"In over twenty years of investigation on the consumption of paracetamol in pregnancy, zero credible investigations has successfully concluded that the consumption of acetaminophen in any stage of gestation results in brain development issues in young ones," the group said.

The court filing cites latest statements from the Trump administration in asserting the medication is reportedly hazardous.

Recently, the former president generated worry from medical authorities when he advised women during pregnancy to "resist strongly" not to take Tylenol when unwell.

The FDA then published an announcement that medical professionals should think about restricting the use of Tylenol, while also stating that "a causal relationship" between the drug and autism in young ones has remains unverified.

The Health Department head Robert F Kennedy Jr, who supervises the FDA, had vowed in April to initiate "a massive testing and research effort" that would establish the cause of autism spectrum disorder in a limited time.

But authorities advised that identifying a single cause of autism - thought by researchers to be the outcome of a complex mix of genetic and external influences - would prove challenging.

Autism is a form of permanent neurological difference and impairment that affects how persons experience and relate to the environment, and is diagnosed using doctors' observations.

In his court filing, the attorney general - aligned with the former president who is seeking US Senate - claims the manufacturer and Johnson & Johnson "intentionally overlooked and tried to quiet the science" around paracetamol and autism.

The case attempts to require the corporations "destroy any commercial messaging" that asserts acetaminophen is secure for women during pregnancy.

This legal action echoes the complaints of a group of parents of children with autism spectrum disorder and ADHD who sued the producers of Tylenol in two years ago.

The court rejected the case, declaring investigations from the plaintiffs' authorities was lacking definitive proof.